Mechanisms of alcoholic heart disease

Jun Ren1, Loren E Wold

  • 1University of Wyoming College of Health Sciences, Laramie, WY 82071, USA. jren@uwyo.edu

Insights

Chronic alcohol use damages heart function through various mechanisms. Animal models, particularly transgenic mice, help study alcoholic cardiomyopathy and acetaldehyde toxicity in the heart.

Area of Science:

  • Cardiology
  • Toxicology
  • Molecular Biology

Background:

  • Chronic alcohol ingestion frequently leads to compromised heart function, including cardiomegaly, reduced contractility, fibrosis, and hypertension.
  • Proposed mechanisms for alcoholic cardiomyopathy involve oxidative damage, lipid deposition, altered fatty acid metabolism, and impaired protein synthesis.
  • Specific alcohol metabolites like acetaldehyde are identified as myocardial toxins, but direct study is challenging.

Purpose of the Study:

  • To review postulated mechanisms of alcoholic cardiomyopathy.
  • To emphasize the role of animal models, especially transgenic mice, in studying these mechanisms.
  • To highlight the challenges and advancements in investigating acetaldehyde's direct impact on cardiac tissue.

Main Methods:

  • Review of existing literature on alcoholic cardiomyopathy.
  • Discussion of proposed molecular and cellular mechanisms.
  • Emphasis on the use of transgenic mouse models to study ethanol and acetaldehyde metabolism.
  • Analysis of acetaldehyde's direct effects on cardiac function and potential toxicity.

Main Results:

  • Acetaldehyde directly impairs cardiac contractile function, excitation-contraction coupling, and promotes oxidative damage.
  • Transgenic mice with altered ethanol/acetaldehyde metabolism allow for elevated acetaldehyde levels post-ethanol ingestion, facilitating study.
  • Animal models provide crucial insights into the pathophysiology of alcoholic cardiomyopathy.

Conclusions:

  • Understanding the precise mechanisms of alcoholic cardiomyopathy remains incomplete.
  • Transgenic animal models offer a viable approach to study the chronic effects of acetaldehyde on the heart.
  • Further research utilizing these models is essential to delineate the underlying causes of alcohol-induced heart disease.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...